Morgan Stanley »

Avita Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $860k 109k 7.92
2024-03-31 $638k 40k 16.03
2023-12-31 $855k 62k 13.72
2023-09-30 $2.3M 159k 14.61
2023-06-30 $613k 36k 17.01
2022-12-31 $118k 18k 6.60
2022-06-30 $290k 68k 4.30
2022-03-31 $298k 35k 8.56
2021-06-30 $0 38k 0.00
2020-12-31 $249k 13k 18.54
2020-09-30 $344k 14k 25.19
2020-06-30 $452k 15k 30.52